1. Home
  2. WST vs LDOS Comparison

WST vs LDOS Comparison

Compare WST & LDOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • LDOS
  • Stock Information
  • Founded
  • WST 1923
  • LDOS 1969
  • Country
  • WST United States
  • LDOS United States
  • Employees
  • WST N/A
  • LDOS N/A
  • Industry
  • WST Medical/Dental Instruments
  • LDOS EDP Services
  • Sector
  • WST Health Care
  • LDOS Technology
  • Exchange
  • WST Nasdaq
  • LDOS Nasdaq
  • Market Cap
  • WST 20.1B
  • LDOS 21.0B
  • IPO Year
  • WST N/A
  • LDOS 2006
  • Fundamental
  • Price
  • WST $299.62
  • LDOS $189.09
  • Analyst Decision
  • WST Strong Buy
  • LDOS Strong Buy
  • Analyst Count
  • WST 8
  • LDOS 13
  • Target Price
  • WST $348.00
  • LDOS $193.75
  • AVG Volume (30 Days)
  • WST 707.3K
  • LDOS 752.2K
  • Earning Date
  • WST 10-23-2025
  • LDOS 11-04-2025
  • Dividend Yield
  • WST 0.30%
  • LDOS 0.84%
  • EPS Growth
  • WST 0.17
  • LDOS 233.94
  • EPS
  • WST 6.75
  • LDOS 10.58
  • Revenue
  • WST $3,017,900,000.00
  • LDOS $17,053,000,000.00
  • Revenue This Year
  • WST $6.49
  • LDOS $5.17
  • Revenue Next Year
  • WST $6.23
  • LDOS $3.59
  • P/E Ratio
  • WST $44.06
  • LDOS $17.95
  • Revenue Growth
  • WST 4.92
  • LDOS 6.53
  • 52 Week Low
  • WST $187.43
  • LDOS $123.62
  • 52 Week High
  • WST $352.33
  • LDOS $202.90
  • Technical
  • Relative Strength Index (RSI)
  • WST 72.87
  • LDOS 51.62
  • Support Level
  • WST $260.12
  • LDOS $180.45
  • Resistance Level
  • WST $322.34
  • LDOS $193.72
  • Average True Range (ATR)
  • WST 7.39
  • LDOS 4.63
  • MACD
  • WST 3.28
  • LDOS -0.52
  • Stochastic Oscillator
  • WST 64.97
  • LDOS 45.88

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About LDOS Leidos Holdings Inc.

Leidos Holdings Inc is a technology, engineering, and science company that provides services and solutions in the defense, intelligence, civil, and health markets, both domestically and internationally. Company customer includes the U.S. Department of Defense ("DoD"), the U.S. Intelligence Community, the U.S. Department of Homeland Security ("DHS"), the Federal Aviation Administration ("FAA"), the Department of Veterans Affairs ("VA"), and many other U.S. civilian, state and local government agencies, etc. The company is engaged in four reportable segments; National Security & Digital, Health & Civil, Commercial & International and Defense Systems. It provides a wide array of scientific, engineering and technical services and solutions across these reportable segments.

Share on Social Networks: